Botox Cosmetic Related Published Studies
Well-designed clinical trials related to Botox Cosmetic (Botulinum Toxin Type A)
A Prospective, Split-Face, Randomized, Double-Blind Study Comparing
OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles. [2015]
The efficacy and safety of liquid-type botulinum toxin type A for the management
of moderate to severe glabellar frown lines. [2015]
The early use of botulinum toxin in post-stroke spasticity: study protocol for a
randomised controlled trial. [2014]
Correlation of botulinum toxin dose with neurophysiological parameters of
efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled,
randomized study. [2014]
Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of
Pisa syndrome in Parkinson disease: a placebo controlled study. [2014]
Botulinum toxin to improve results in cleft lip repair. [2014]
Botulinum toxin a does not decrease calf pain or improve ROM during limb
lengthening: a randomized trial. [2014]
Safety and efficacy of botulinum toxin in primary orthostatic tremor. [2013]
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled
subgroup analysis of patients who had acute headache medication overuse at
baseline. [2013]
Upper extremity spasticity in children with cerebral palsy: a randomized,
double-blind, placebo-controlled study of the short-term outcomes of treatment
with botulinum A toxin. [2013]
Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in
patients receiving botulinum toxin therapy. [2013]
Combined use of botulinum toxin type A and B for forehead rhytides: a randomized,
double-blind, split-face study. [2013]
Effectiveness of type A botulinum toxins for aesthetic indications and their
relative economic impact. [2012]
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. [2012]
Botulinum toxin effects on gasatrocnemius strength and plantar pressure in
diabetics with peripheral neuropathy and forefoot ulceration. [2012]
Modification of altered ankle motor control after stroke using focal application
of botulinum toxin type A. [2012]
Vandetanib: in medullary thyroid cancer. [2012]
Botulinum toxin injection for hypertonicity of the upper extremity within 12
weeks after stroke: a randomized controlled trial. [2012]
Immunoresistance in cervical dystonia patients after treatment with
abobotulinumtoxinA. [2012]
Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a
randomised blinded placebo-controlled trial of 240 women (the RELAX study). [2012]
Prospective randomized comparison of onabotulinumtoxinA (Botox) and
abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and
periorbital wrinkles. [2012]
Topical diltiazem cream versus botulinum toxin a for the treatment of chronic
anal fissure: a double-blind randomized clinical trial. [2012]
A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer. [2011.09]
Botulinum toxin injection for management of thoracic outlet syndrome: a double-blind, randomized, controlled trial. [2011.09]
Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. [2011.08]
Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A. [2011.07]
Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study. [2011.07]
Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial. [2011.06]
[Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique]. [2011.05]
Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain. [2011.05]
Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study. [2011.05]
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. [2011.04]
Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial. [2011.03]
Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial. [2011.03]
Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. [2011.02.01]
Functional electrical stimulation combined with botulinum toxin type A to improve hand function in children with spastic hemiparesis - a pilot study. [2011.02]
Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy--a randomized controlled study. [2011.02]
Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm. [2011.02]
A pilot study of botulinum toxin A for male chronic pelvic pain syndrome. [2011.02]
[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [2011.01]
Prophylactic botulinum type A toxin complex (Dysport(R)) for migraine without aura. [2011.01]
A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. [2011.01]
Long-term efficacy and respective potencies of botulinum toxin A and B: a randomized, double-blind study. [2011.01]
Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial. [2011]
Implications of current clinical trials focused on medication overuse and
therapeutic prophylaxis. [2011]
Time to onset of response of abobotulinumtoxina in the treatment of glabellar
lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type
A. [2011]
The safety and efficacy of botulinum toxin-A in the management of bladder
oversensitivity: a randomised double-blind placebo-controlled trial. [2011]
Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD
pain: a randomized, controlled, double-blind multicenter study. [2011]
[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [Article in French] [2011]
Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a
randomized, double-blinded, controlled multicentre clinical trial. [2011]
Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura. [2011]
Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data
analysis. [2011]
Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. [2010.12]
Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks? [2010.12]
Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. [2010.12]
Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines. [2010.12]
Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study. [2010.12]
Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. [2010.12]
Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. [2010.12]
A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem. [2010.12]
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. [2010.12]
Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial. [2010.12]
Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. [2010.12]
Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone. [2010.11]
Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial. [2010.11]
Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a randomized controlled trial. [2010.11]
Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses. [2010.11]
Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections. [2010.10]
Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study. [2010.09]
The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. [2010.07]
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. [2010.07]
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. [2010.07]
A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. [2010.05]
Urodynamic effects of once daily tadalafil in men with lower urinary tract
symptoms secondary to clinical benign prostatic hyperplasia: a randomized,
placebo controlled 12-week clinical trial. [2010]
The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors
spasticity after stroke. [2010]
OnabotulinumtoxinA for treatment of chronic migraine: results from the
double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. [2010]
OnabotulinumtoxinA for treatment of chronic migraine: results from the
double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. [2010]
Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a
pilot study. [2010]
Botulinum toxin type A in post-stroke upper limb spasticity. [2010]
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the
double-blind, randomized, placebo-controlled phases of the PREEMPT clinical
program. [2010]
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter,
double-blind, placebo-controlled trial. [2010]
Diode laser hair removal does not interfere with botulinum toxin A treatment
against axillary hyperhidrosis. [2010]
Goal attainment scaling in the evaluation of treatment of upper limb spasticity
with botulinum toxin: a secondary analysis from a double-blind placebo-controlled
randomized clinical trial. [2010]
Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity. [2010]
Supraciliary wrinkles and botulinum toxin A. [2010]
Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled
trial. [2010]
Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study. [2009.10]
An open-label, randomized, 64-week study repeating 10- and 20-U doses of botulinum toxin type A for treatment of glabellar lines in Japanese subjects. [2009.07]
Reduction of pain and anxiety prior to botulinum toxin injections with a new topical anesthetic method. [2009.05]
Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. [2009.05]
A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI. [2009.03]
The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A. [2008.12]
The effects of one botulinum toxin type A (BTX-A) injection after UPPP. [2008.10]
The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study. [2008.08]
Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids. [2007.11]
Botulinum toxin A adjunctive use in manual chemabrasion: controlled long-term study for treatment of upper perioral vertical wrinkles. [2007.09]
A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type a in the treatment of lateral orbital rhytides. [2007.05]
A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides. [2007.04]
UV-B irradiation attenuates dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study. [2007.01]
Patient-reported outcomes with botulinum toxin type a treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study. [2007.01]
|